Core Laboratories N.V. (CLB)

Core Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	37.52	36.68	19.45	19.73	-97.64	101.98
Depreciation & Amortization	15.58	15.78	17.16	18.52	20.87	22.61
Share-Based Compensation	9.81	13.97	7.76	19.09	7.39	20.88
Other Operating Activities	-29.42	-41.64	-19.41	-20.76	127.24	-55.94
Operating Cash Flow	33.49	24.79	24.96	36.58	57.87	89.53
Operating Cash Flow Growth	102.99%	-0.67%	-31.78%	-36.79%	-35.36%	-19.94%
Capital Expenditures	-10.45	-10.03	-8.36	-13.18	-10.64	-21.56
Acquisitions	0	0	0.24	0.87	-0.23	17.77
Other Investing Activities	4.18	3.38	4.26	2.08	18.72	-1.88
Investing Cash Flow	-6.27	-6.65	-3.86	-10.22	7.85	-5.68
Dividends Paid	-1.87	-1.87	-1.85	-1.83	-12.45	-97.57
Share Issuance / Repurchase	-2.25	-2.2	-3.9	51.74	-2.79	-3.31
Debt Issued / Paid	-21.27	-10.25	-17.21	-71	-47.54	15
Other Financing Activities	-3.2	-4.12	-0.41	-1.37	-0.23	0.01
Financing Cash Flow	-28.59	-18.45	-23.38	-22.46	-63.01	-85.87
Net Cash Flow	-1.37	-0.31	-2.28	3.9	2.71	-2.02
Free Cash Flow	23.04	14.76	16.6	23.4	47.22	67.97
Free Cash Flow Growth	176.49%	-11.07%	-29.06%	-50.45%	-30.52%	-24.30%
Free Cash Flow Margin	4.51%	2.90%	3.39%	4.98%	9.69%	10.17%
Free Cash Flow Per Share	0.49	0.32	0.36	0.51	1.06	1.53

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).